231 related articles for article (PubMed ID: 27856665)
21. EGR2 Deletion Suppresses Anti-DsDNA Autoantibody and IL-17 Production in Autoimmune-Prone B6/lpr Mice: A Differential Immune Regulatory Role of EGR2 in B6/lpr Versus Normal B6 Mice.
Dai R; Wang Z; Heid B; Eden K; Reilly CM; Ahmed SA
Front Immunol; 2022; 13():917866. PubMed ID: 35784356
[TBL] [Abstract][Full Text] [Related]
22. Splicing factor SRSF1 controls distinct molecular programs in regulatory and effector T cells implicated in systemic autoimmune disease.
Cassidy MF; Herbert ZT; Moulton VR
Mol Immunol; 2022 Jan; 141():94-103. PubMed ID: 34839165
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-17 and systemic lupus erythematosus: current concepts.
Nalbandian A; Crispín JC; Tsokos GC
Clin Exp Immunol; 2009 Aug; 157(2):209-15. PubMed ID: 19604260
[TBL] [Abstract][Full Text] [Related]
24. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
25. Cbl-b(-/-) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-beta.
Adams CO; Housley WJ; Bhowmick S; Cone RE; Rajan TV; Forouhar F; Clark RB
J Immunol; 2010 Aug; 185(4):2051-8. PubMed ID: 20624942
[TBL] [Abstract][Full Text] [Related]
26. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
27. Egr3 induces a Th17 response by promoting the development of γδ T cells.
Parkinson RM; Collins SL; Horton MR; Powell JD
PLoS One; 2014; 9(1):e87265. PubMed ID: 24475259
[TBL] [Abstract][Full Text] [Related]
28. Myeloid-Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus.
Park MJ; Lee SH; Kim EK; Lee EJ; Park SH; Kwok SK; Cho ML
Arthritis Rheumatol; 2016 Nov; 68(11):2717-2727. PubMed ID: 27214349
[TBL] [Abstract][Full Text] [Related]
29. The role of CD4CD25 T cells in autoantibody production in murine lupus.
Hsu WT; Suen JL; Chiang BL
Clin Exp Immunol; 2006 Sep; 145(3):513-9. PubMed ID: 16907921
[TBL] [Abstract][Full Text] [Related]
30. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
[TBL] [Abstract][Full Text] [Related]
31. EGR3 as a potential susceptibility gene for schizophrenia in Korea.
Kim SH; Song JY; Joo EJ; Lee KY; Ahn YM; Kim YS
Am J Med Genet B Neuropsychiatr Genet; 2010 Oct; 153B(7):1355-60. PubMed ID: 20687139
[TBL] [Abstract][Full Text] [Related]
32. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
Sharabi A; Lapter S; Mozes E
J Autoimmun; 2010 Mar; 34(2):87-95. PubMed ID: 19596183
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D supplementation effects on FoxP3 expression in T cells and FoxP3
Marinho A; Carvalho C; Boleixa D; Bettencourt A; Leal B; Guimarães J; Neves E; Oliveira JC; Almeida I; Farinha F; Costa PP; Vasconcelos C; Silva BM
Immunol Res; 2017 Feb; 65(1):197-206. PubMed ID: 27423437
[TBL] [Abstract][Full Text] [Related]
34. Superantigen influence in conjunction with cytokine polymorphism potentiates autoimmunity in systemic lupus erythematosus patients.
Dar SA; Janahi EM; Haque S; Akhter N; Jawed A; Wahid M; Ramachandran VG; Bhattacharya SN; Banerjee BD; Das S
Immunol Res; 2016 Aug; 64(4):1001-12. PubMed ID: 26676360
[TBL] [Abstract][Full Text] [Related]
35. A peptide that ameliorates lupus up-regulates the diminished expression of early growth response factors 2 and 3.
Sela U; Dayan M; Hershkoviz R; Lider O; Mozes E
J Immunol; 2008 Feb; 180(3):1584-91. PubMed ID: 18209054
[TBL] [Abstract][Full Text] [Related]
36. Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease.
Hadaschik EN; Wei X; Leiss H; Heckmann B; Niederreiter B; Steiner G; Ulrich W; Enk AH; Smolen JS; Stummvoll GH
Arthritis Res Ther; 2015 Feb; 17(1):35. PubMed ID: 25890083
[TBL] [Abstract][Full Text] [Related]
37. Egr2 and Egr3 are the unique regulators for systemic autoimmunity.
Sumitomo S; Fujio K; Okamura T; Yamamoto K
JAKSTAT; 2013 Apr; 2(2):e23952. PubMed ID: 24058814
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S
Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237
[TBL] [Abstract][Full Text] [Related]
39. Prevention and control of reciprocal T-B cell diversification: implications for lupus-like autoimmunity.
Singh RR
Mol Immunol; 2004 Feb; 40(14-15):1137-45. PubMed ID: 15036920
[TBL] [Abstract][Full Text] [Related]
40. ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
Aggelakopoulou M; Kourepini E; Paschalidis N; Panoutsakopoulou V
J Immunol; 2016 Jun; 196(12):4947-56. PubMed ID: 27183630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
